Genetic testing supply for cancer diagnosis and care outstrips demand
Genetic testing, particularly to determine risk or early detection of cancer, is becoming more prevalent and available yet, in economic terms, supply outstrips demand.
Genetic testing, particularly to determine risk or early detection of cancer, is becoming more prevalent and available yet, in economic terms, supply outstrips demand.
What does it take to find leadership that can claim victory in vertical integration in healthcare? Is it different than other industries?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The cost implication of providing health coverage for transgenders is minuscule when compared to other chronic diseases, given that 0.1 percent to 0.5 percent of a company's workforce would make a claim for these services.
Would free telemedicine visits for health plan members flood the healthcare system with unnecessary consultations that would actually drive costs up? Or could it prove a significant cost saver in the long run?